These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 17990062)

  • 21. Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.
    Chang KH; Chen YC; Wu YR; Lee WF; Chen CM
    PLoS One; 2012; 7(9):e46492. PubMed ID: 23029535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
    Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
    Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Xu EH; Tang Y; Li D; Jia JP
    J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.
    Saft C; Zange J; Andrich J; Müller K; Lindenberg K; Landwehrmeyer B; Vorgerd M; Kraus PH; Przuntek H; Schöls L
    Mov Disord; 2005 Jun; 20(6):674-9. PubMed ID: 15704211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
    Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
    J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
    Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
    Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress in families of type 1 diabetic patients.
    Matteucci E; Giampietro O
    Diabetes Care; 2000 Aug; 23(8):1182-6. PubMed ID: 10937519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early sympathetic hyperactivity in Huntington's disease.
    Kobal J; Meglic B; Mesec A; Peterlin B
    Eur J Neurol; 2004 Dec; 11(12):842-8. PubMed ID: 15667417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):206-11. PubMed ID: 19548952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
    J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease.
    van de Zande NA; Bulk M; Najac C; van der Weerd L; de Bresser J; Lewerenz J; Ronen I; de Bot ST
    Neuroimage Clin; 2023; 39():103450. PubMed ID: 37327706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-theta border EEG abnormalities in preclinical Huntington's disease.
    Ponomareva N; Klyushnikov S; Abramycheva N; Malina D; Scheglova N; Fokin V; Ivanova-Smolenskaia I; Illarioshkin S
    J Neurol Sci; 2014 Sep; 344(1-2):114-20. PubMed ID: 25015843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte telomere shortening in Huntington's disease.
    Scarabino D; Veneziano L; Peconi M; Frontali M; Mantuano E; Corbo RM
    J Neurol Sci; 2019 Jan; 396():25-29. PubMed ID: 30396032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington's Disease Monkeys.
    Clever F; Cho IK; Yang J; Chan AWS
    J Huntingtons Dis; 2019; 8(4):443-448. PubMed ID: 31561381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression changes in blood as a putative biomarker for Huntington's disease.
    Lovrecic L; Kastrin A; Kobal J; Pirtosek Z; Krainc D; Peterlin B
    Mov Disord; 2009 Nov; 24(15):2277-81. PubMed ID: 19844910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.